Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Omnicare Pays $50M to Settle Federal Case

By Pharmaceutical Processing | May 14, 2012

CLEVELAND (AP) — Omnicare will pay $50 million to settle allegations that it improperly dispensed drugs for nursing home patients without a doctor’s signed prescription since 2007, the government announced Friday.

U.S. Attorney Steven Dettelbach said at a news conference that it was the second largest monetary settlement nationally in the history of the Controlled Substances Act regulating drugs.

The Covington, Ky.-based company, which sells drugs to long-term care providers like hospitals and nursing homes, said there were no allegations that drugs were illegally diverted to someone without prescriptions and no patients were harmed.

The charges stemmed from a previously announced investigation by the Drug Enforcement Administration.

At issue was how pharmacy managers communicate with doctors who write prescriptions for controlled substances.

The civil penalty resolves government claims that Omnicare improperly dispensed addictive painkillers and other drugs to patients at nursing homes and other health-care facilities it serves, sometimes dispensing without prescriptions.

Even with a prescription, the medication order sometimes omitted the drug name, dose, strength and quantity, the government said.

Asked about the motive, Dettelbach said the case was a civil matter, not criminal, and added, “There is a lot of profit that happens with the dispensation of high volumes of these medicines.”

Dettelbach said the case was meant to send a message. “Doctors need to be involved in the key care decisions regarding patients involving providing these controlled substances,” he said.

Omnicare said that the settlement with the Justice Department recognizes that whoever prescribes a drug must either sign an order containing all of the elements of the prescription or, in emergency situations, speak directly to the pharmacy.

Omnicare said that pharmacies in long-term care facilities have historically operated in a less defined “middle ground.” Sometimes they dispensed drugs on the instruction of staff at the facility.

“We believe this settlement provides long-term care pharmacies, long-term care facilities and prescribers with clear direction regarding the procedures that must be followed when dispensing controlled substances,” Omnicare CEO John Figueroa said.

Shares of Omnicare Inc. rose 72 cents, or 2 percent, to $35.18. The stock has $20.36 and $36.48 over the last year.

Dettelbach said nurses or others involved in giving patients drugs that were improperly dispensed by Omnicare were not the focus of the investigation.

 

 

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE